Approximately 10% of patients with CAH have CAH-X syndrome due to the presence of a monoallelic nonfunctional TNXB/TNXA chimeric gene in combination with another CYP21A2 pathogenic mutation in the second allele [2]. The gene discussed is CYP21A2; the disease is congenital adrenal hyperplasia.